CARNMT1 and cancer: Thus, U2AF1 in the CARNMT1 KO cells behaves similarly to the U2AF1 S34F/Y mutants, raising a fascinating question: Do these cancer-associated mutations mimic a cell state in which CARNMT1 activity is physiologically down-regulated to execute a specific splicing program?